journal article Mar 01, 1997

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

The Lancet Vol. 349 No. 9056 pp. 902-906 · Elsevier BV
View at Publisher Save 10.1016/s0140-6736(96)06453-7
Topics

No keywords indexed for this article. Browse by subject →

References
17
[1]
Miller "Multiple sclerosis: treatment of acute exacerbations with corticotrophin (ACTH)" Lancet (1961) 10.1016/s0140-6736(61)91030-3
[2]
Rose "Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH versus placebo" Neurology (1970)
[3]
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

N M Milligan, R Newcombe, D A Compston

Journal of Neurology, Neurosurgery & Psych... 1987 10.1136/jnnp.50.5.511
[4]
Alam "Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose" J Neurol Neurosurg Psychiatry (1993) 10.1136/jnnp.56.11.1219
[5]
Beck "The effect of corticosteroids in acute optic neuritis on the subsequent development of multiple sclerosis" N Engl J Med (1993) 10.1056/nejm199312093292403
[6]
Kurtzke "Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)" Neurology (1983) 10.1212/wnl.33.11.1444
[7]
Thompson "Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS" Neurology (1989) 10.1212/wnl.39.7.969
[8]
Matthews "Analysis of serial measurements in medical research" BMJ (1990) 10.1136/bmj.300.6719.230
[9]
Double-Blind Trial of Dexamethasone versus Methylprednisolone in Multiple Sclerosis Acute Relapses

L. La Mantia, M. Eoli, C. Milanese et al.

European Neurology 1994 10.1159/000117038
[10]
Barnes "Intravenous methylprednisolone for multiple sclerosis" J Neurol Neurosurg Psychiatry (1985) 10.1136/jnnp.48.2.157
[11]
Kupersmith "Megadose corticosteroids in multiple sclerosis" Neurology (1994) 10.1212/wnl.44.1.1
[12]
Miller "High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanisms of therapeutic effect" J Neurol Neurosurg Psychiatry (1992) 10.1136/jnnp.55.6.450
[13]
Barkhof "Quantitative MRI changes in gadolinium DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis" Neurology (1991) 10.1212/wnl.41.8.1219
[14]
Beck "A randomisation controlled trial of corticosteroids in the treatment of acute optic neuritis" N Engl J Med (1992) 10.1056/nejm199202273260901
[15]
Beck "The Optic Neuritis Treatment Trial: three-year follow-up results" Arch Opthalmol (1995) 10.1001/archopht.1995.01100020014004
[16]
Defer "Methylprednisolone infusion during acute exacerbation of MS: plasma and CSF concentrations" Eur Neurol (1995) 10.1159/000117110
[17]
Lyons "Methylprednisolone therapy in multiple sclerosis. A profile of adverse events" J Neurol Neurosurg Psychiatry (1988) 10.1136/jnnp.51.2.285
Metrics
148
Citations
17
References
Details
Published
Mar 01, 1997
Vol/Issue
349(9056)
Pages
902-906
License
View
Cite This Article
D Barnes, RAC Hughes, RW Morris, et al. (1997). Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. The Lancet, 349(9056), 902-906. https://doi.org/10.1016/s0140-6736(96)06453-7